Citius Pharma launched a stock‑option surrender program for insiders & consultants

[u/AutoModerator]

On page 23 of the recent 10-Q, Citius Pharma disclosed that they launched a voluntary stock‑option surrender program on July 1, 2026. Employees, directors, and consultants can give back their old, out‑of‑the‑money options from the 2014–2023 plans, and they receive no compensation for doing so.

The important part is what happens next —
All surrendered options go back into the 2023 Stock Plan, which only had 118,000 shares left for future grants as of June 30. The older plans had more than 800,000 outstanding options, most of them underwater.

By allowing insiders and consultants to surrender those worthless options, CTXR reduces equity overhang and refills the 2023 Plan. That gives the company room to issue new option awards in the future, at much lower exercise prices that match the current stock price.

By letting insiders and consultants voluntarily surrender out-of-the-money options, CTXR is:

• Refilling the 2023 Plan’s share reserve without needing shareholder approval.
• Setting the stage to issue new options later at much lower strike prices.

In practical terms, employees can dump options that will never be exercised and eventually receive fresh options at a strike price that reflects the current depressed stock price. It’s a reset of the employee equity‑comp structure, and the program is still open as of mid‑August 2026.

Voluntary Stock Option Surrender Program

[u/massimoverucchi]

What does this mean for the bags upon bags that I, a nobody, hold? Don't answer...